Search results
Seagen is a global team of scientists, engineers, clinicians, advocates, and innovators with a shared commitment to transforming cancer care. We’re dedicated to creating a culture of integrity, collaboration, and diversity, where your drive will make a difference.
- Leadership
Mr. Epstein joined Seagen as Chief Executive Officer and a...
- Our Medicines
Report an adverse event or request additional information...
- Healthcare Professional
Seagen is a global biotechnology company dedicated to...
- Who We Are
Seagen is committed to securing patient access to our...
- Featured Content
Learn how Seagen is revolutionizing cancer care through our...
- Science and Research
Seagen is developing a new generation of targeted, empowered...
- Leadership
Dec 14, 2023 · Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion. “Cancer remains a leading cause of death, and one in three people in the U.S. will receive a cancer diagnosis in their lifetime.
Dec 14, 2023 · Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion. "Cancer remains a leading cause of ...
Seagen Inc. (formerly Seattle Genetics, Inc.) is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody -based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle ), is the industry leader in antibody-drug conjugates or ADCs ...
- 1997; 26 years ago
- Bothell, Washington, U.S.
- 3,256 (2022)
- US$1.96 billion (2022)
And now, we’re making significant investments to tackle cancer – one of the biggest health challenges of our lifetime. With the addition of Seagen, a world-leader in antibody-drug conjugates (ADCs), we will be at the forefront of cancer care. Together, we will bring new hope to patients everywhere.
Dec 14, 2023 · December 14, 2023 07:39 AM Eastern Standard Time. NEW YORK-- ( BUSINESS WIRE )--Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Seagen Inc. (NASDAQ: SGEN ...
People also ask
What does SeaGen do?
Did Pfizer buy SeaGen?
What does SeaGen stand for?
What makes SeaGen unique?
Mar 13, 2023 · Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion Proposed combination enhances Pfizer’s position as a leading company in Oncology Seagen’s medicines, late-stage development programs and pioneering expertise in Antibody-Drug Conjugates (ADCs) strongly complement Pfizer’s Oncology portfolio Seagen expected to contribute ...
